Literature DB >> 2554297

Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy.

J M Shoffner1, M T Lott, A S Voljavec, S A Soueidan, D A Costigan, D C Wallace.   

Abstract

The muscle mitochondria of a patient with Kearns-Sayre/chronic external ophthalmoplegia plus syndrome were found to be completely deficient in respiratory complex I activity and partially deficient in complex IV and V activities. Treatment of the patient with coenzyme Q10 and succinate resulted in clinical improvement of respiratory function, consistent with the respiratory deficiencies. Restriction enzyme analysis of the muscle mtDNA revealed a 4.9-kilobase deletion in 50% of the mtDNA molecules. Polymerase chain reaction analysis demonstrated that the deletion was present in the patient's muscle but not in her lymphocytes or platelets. Furthermore, the deletion was not present in the muscle or platelets of two sisters. Hence, the mutation probably occurred in the patient's somatic cells. Direct sequencing of polymerase chain reaction-amplified DNA revealed a 4977-base-pair deletion removing four genes for subunits of complex I, one gene for complex IV, two genes for complex V, and five genes for tRNAs, which paralleled the respiratory enzymes affected in the disease. A 13-base-pair direct repeat was observed upstream from both breakpoints. Relative to the direction of heavy-strand replication, the first repeat was retained and the second repeat was deleted, suggesting a slip-replication mechanism. Sequence analysis of the human mtDNA revealed many direct repeats of 10 base pairs or greater, indicating that this mechanism could account for other reported deletions. We postulate that the prevalence of direct repeats in the mtDNA is a consequence of the guanine-cytosine bias of the heavy and light strands.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554297      PMCID: PMC298190          DOI: 10.1073/pnas.86.20.7952

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration.

Authors:  M Yamamoto; T Sato; M Anno; H Ujike; M Takemoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome.

Authors:  S Ogasahara; S Yorifuji; Y Nishikawa; M Takahashi; K Wada; T Hazama; Y Nakamura; S Hashimoto; N Kono; S Tarui
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

4.  A comprehensive sequence analysis program for the IBM personal computer.

Authors:  C Queen; L J Korn
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

6.  The complete nucleotide sequence of the Xenopus laevis mitochondrial genome.

Authors:  B A Roe; D P Ma; R K Wilson; J F Wong
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

7.  Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy.

Authors:  S Goda; T Hamada; S Ishimoto; T Kobayashi; I Goto; Y Kuroiwa
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

8.  Treatment of Kearns-Sayre syndrome with coenzyme Q10.

Authors:  S Ogasahara; Y Nishikawa; S Yorifuji; F Soga; Y Nakamura; M Takahashi; S Hashimoto; N Kono; S Tarui
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

9.  Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies.

Authors:  I J Holt; A E Harding; J A Morgan-Hughes
Journal:  Nature       Date:  1988-02-25       Impact factor: 49.962

10.  Antioxidative effect of ubiquinones on mitochondrial membranes.

Authors:  L Landi; L Cabrini; A M Sechi; P Pasquali
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

View more
  117 in total

1.  A unique junctional palindromic sequence in mitochondrial DNA from a patient with progressive external ophthalmoplegia.

Authors:  T Saiwaki; K Shiga; R Fukuyama; Y Tsutsumi; S Fushiki
Journal:  Mol Pathol       Date:  2000-12

2.  Mitochondrial DNA deletion mutations are concomitant with ragged red regions of individual, aged muscle fibers: analysis by laser-capture microdissection.

Authors:  Z Cao; J Wanagat; S H McKiernan; J M Aiken
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

3.  Detection of a specific mitochondrial DNA deletion in tissues of older humans.

Authors:  G A Cortopassi; N Arnheim
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 4.  Bacterial NADH-quinone oxidoreductases.

Authors:  T Yagi
Journal:  J Bioenerg Biomembr       Date:  1991-04       Impact factor: 2.945

5.  Departure of human mitochondrial DNA variation from neutral expectations: an alternative explanation.

Authors:  M Stoneking
Journal:  J Mol Evol       Date:  1990-10       Impact factor: 2.395

6.  Analysis of repeat-mediated deletions in the mitochondrial genome of Saccharomyces cerevisiae.

Authors:  Naina Phadnis; Rey A Sia; Elaine A Sia
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

7.  Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion.

Authors:  A Barrientos; J Casademont; A Saiz; F Cardellach; V Volpini; A Solans; E Tolosa; A Urbano-Marquez; X Estivill; V Nunes
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

8.  Pearson bone marrow-pancreas syndrome with insulin-dependent diabetes, progressive renal tubulopathy, organic aciduria and elevated fetal haemoglobin caused by deletion and duplication of mitochondrial DNA.

Authors:  A Superti-Furga; E Schoenle; P Tuchschmid; R Caduff; V Sabato; D DeMattia; R Gitzelmann; B Steinmann
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

Review 9.  Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification.

Authors:  Gert Van Goethem; Jean-Jacques Martin; Christine Van Broeckhoven
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

10.  The exonuclease activity of the yeast mitochondrial DNA polymerase γ suppresses mitochondrial DNA deletions between short direct repeats in Saccharomyces cerevisiae.

Authors:  Jeffrey D Stumpf; William C Copeland
Journal:  Genetics       Date:  2013-04-15       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.